Breaking News
April 23, 2019 - Sensory Sensitivity Tied to Constipation in Young Children
April 23, 2019 - More than half of internal medicine graduates choosing primary care
April 22, 2019 - Researchers discover good news for fish populations living on bleached coral reefs
April 22, 2019 - Plant-based diets associated with lower risk of heart failure
April 22, 2019 - Food Allergies Can Strike at Any Age
April 22, 2019 - Cerebro-facio-thoracic dysplasia – Genetics Home Reference
April 22, 2019 - Poverty leaves a mark on our genes
April 22, 2019 - Countdown to Big Data in Precision Health: When industry and academia converge
April 22, 2019 - The U.S government may account for up to $37.8 billion due to opioid epidemic
April 22, 2019 - Improving ACA’s Insurance Coverage Provisions will lead to better care for patients
April 22, 2019 - Study identifies possible therapeutic effects of curcumin on stomach cancer
April 22, 2019 - Hyaline fibromatosis syndrome – Genetics Home Reference
April 22, 2019 - Scientists use CRISPR for possible ‘bubble boy’ therapy
April 22, 2019 - Hematologist (and a mom, singer, actress and much more) stands up for diversity
April 22, 2019 - Novel AI voice tool can help diagnose PTSD
April 22, 2019 - Overlooked part of cell’s internal machinery may hold key to treating acute myeloid leukemia
April 22, 2019 - Soft bedding responsible for majority of sleep-related infant deaths, study reveals
April 22, 2019 - Study finds worse health-related quality of life among transgender adults
April 22, 2019 - MIT scientists reverse some behavioral symptoms of rare neurodevelopmental disorder
April 22, 2019 - Scientists find new therapy target for drug-induced liver failure
April 22, 2019 - Opioid dose variability could lead to increased risk of overdose, study suggests
April 22, 2019 - Newly developed model predicts salmonella outbreaks several months in advance
April 22, 2019 - Deep-learning model better predicts survival outcomes for lung cancer
April 22, 2019 - One in Three U.S. Adults Aged 35 to 44 May Have Drinking Problem
April 22, 2019 - Why the measles virus is so contagious
April 22, 2019 - Magnet ‘Zap’ to the Brain Might Jumpstart Aging Memory
April 22, 2019 - Immune response to gut microbes may be early indicator of type 1 diabetes
April 22, 2019 - Destination Limbo: Health Suffers Among Asylum Seekers In Crowded Border Shelter
April 22, 2019 - Research shows how dopamine contributes to sex differences in worms
April 22, 2019 - Marijuana users weigh less compared to non-users
April 22, 2019 - Research uncovers critical RNA processing aberrations in ALS and FTD
April 22, 2019 - Many cancer patients use marijuana and prescription opioids, study reveals
April 22, 2019 - Frailty may up fracture risk in patients with type 2 diabetes
April 22, 2019 - Study provides new insight into how obesity, insulin resistance can affect cognition
April 22, 2019 - Study seeks to better understand the genetic causes for hypospadias
April 22, 2019 - FDA grants approval of first generic naloxone nasal spray to treat opioid overdose
April 22, 2019 - FDA authorizes marketing of first medical device to treat ADHD
April 22, 2019 - Vanderbilt researchers to develop and test ‘safe harbor’ standards of care
April 22, 2019 - You’re probably brushing your teeth wrong – here are four tips for better dental health
April 22, 2019 - Pharmacy closures contribute to medication non-adherence among heart patients
April 22, 2019 - Using Edge AI technology to observe behavior of cattle
April 22, 2019 - Bacteria play a role in the development of stomach ulcers in pigs
April 22, 2019 - Hand Hygiene Compliance Poor in Task Transitions
April 22, 2019 - smoking could harm your baby
April 22, 2019 - Scientists identify rare, paradoxical response to antiretroviral therapy
April 21, 2019 - More TV, Tablets, More Attention Issues at Age 5
April 21, 2019 - Drug reduces risk of kidney failure in people with diabetes, study finds
April 21, 2019 - New research identifies novel link between antibiotic resistance and climate change
April 21, 2019 - Simple intervention can provide lasting protection for teens against junk food marketing
April 21, 2019 - The protein p38-gamma identified as a new therapeutic target in liver cancer
April 21, 2019 - Novel system enables researchers to study bacteria within mini-tissues in a dish
April 21, 2019 - Discovery of oral cancer biomarkers could save thousands of lives
April 21, 2019 - Geneva Exhibition committee gives gold medals to two medications developed by Kazan
April 21, 2019 - Scientists aim to minimize or eliminate hair loss during cancer treatment
April 21, 2019 - WiFi interacts with signaling pathways in the human brain
April 21, 2019 - Stroke Hospitalizations Down in Black, White Medicare Enrollees
April 21, 2019 - First common risk genes discovered for autism
April 21, 2019 - Researchers map auditory sensory system of the mouse brain
April 21, 2019 - Scientists Bring Pig’s Brain, Dead 4 Hours, Back to ‘Cellular Activity’
April 21, 2019 - Virtual reality a promising tool for reducing fears and phobia in autism
April 21, 2019 - New analysis lists out opportunities for U.S. medical schools to advance population health
April 21, 2019 - More sleep may help teens with ADHD focus and organize
April 21, 2019 - Breakthrough antibody treatment suppresses HIV without antivirals
April 21, 2019 - AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA) Type 1
April 21, 2019 - Is your hand pain arthritis, carpal tunnel or something else?
April 21, 2019 - Measles outbreaks may become more frequent if vaccination rates continue to decline
April 21, 2019 - Researchers succeed in accelerating process of creating 3D images
April 21, 2019 - Tiny worm mimics key genetic risk for Alzheimer’s
April 21, 2019 - Angry dreams explained by brain waves
April 20, 2019 - Parenteral Antimicrobial Tx at Home Burdens Children’s Caregivers
April 20, 2019 - Diabetes treatment may keep dementia, Alzheimer’s at bay
April 20, 2019 - New bandage-like biosensor collects and analyzes sweat
April 20, 2019 - A comprehensive, centralized database of bovine milk compounds
April 20, 2019 - Two new epigenetic regulators maintain self-renewal of embryonic stem cells
April 20, 2019 - New Evidence That Veggies Beat Steak for Heart Health
April 20, 2019 - Study reveals genes associated with heavy drinking and alcoholism
April 20, 2019 - Texas A&M AgriLife becomes the newest member of NutriRECS international consortium
April 20, 2019 - In most states, insurance won’t cover addiction treatments
April 20, 2019 - Computer-based memory games may be beneficial for individuals with fragile X syndrome
April 20, 2019 - Timing of food intake influences molecular clock in the liver of mice
Human microbiome metabolites enhance colon injury by enterohemorrhagic E. coli, study shows

Human microbiome metabolites enhance colon injury by enterohemorrhagic E. coli, study shows

image_pdfDownload PDFimage_print

It remains mysterious why humans get infected by some bacterial or viral pathogens relatively easily while animals that have very similar tissues and immune functions do not. This chasm also is the reason why researchers frequently face problems in their efforts to model pathogenic diseases in animal models, such as mice, and why drugs developed using this approach often fail in humans.

A striking example of species-specific differences in tolerance to infection can be seen in the response to enterohemorrhagic E. coli (EHEC) bacteria, which are responsible for more than 100,000 infections per year alone in the U.S., and the cause of bloody diarrhea (travel diarrhea), colitis and hemolytic uremic syndrome (HUS) – a serious condition that induces kidneys to fail after they encounter EHEC’s Shiga toxin. For years it has been known that it takes 100,000-fold higher numbers of pathogenic EHEC bacteria to infect mice compared to humans, and that mice don’t develop symptoms of the disease unless the animals are grown under special germ-free conditions in which they lack a normal commensal gut microbiome.

A multi-disciplinary team of biological engineers, microbiologists, and systems biologists at Harvard’s Wyss Institute for Biologically Inspired Engineering working on the Institute’s DARPA-supported “Technologies for Host Resilience” (THoR) Project, whose goal it is to uncover the causes of tolerance to infection exhibited by certain individuals or species, has now succeeded in modeling infection of human colon with EHEC in vitro using a microfluidic Organ-on-a-Chip (Organ Chip) culture device. Surprisingly, their approach enabled the identification of key differences between the metabolites produced by the complex communities of commensal bacteria that comprise the microbiome present in the mouse versus human colon. They found that four metabolites that are produced at higher levels by the human gut microbiome can help explain the enhanced sensitivity of human colon towards EHEC. The study was published in Microbiome.

“We were motivated by the observation that there are often enormous differences in sensitivity between human and mouse intestine when challenged with same pathogen, and past work that has shown that some of these differences in tolerance to infection can be explained by differences in the gut microbiome between these species,” said Wyss Institute Founding Director Donald Ingber, M.D., Ph.D., who led the study. “To attack this problem directly, we leveraged our human Organ Chip technology and combined it with microbial metabolites produced in bioreactors, as well as metabolomic analysis, to gain insight into the molecular basis for this species-specific difference in sensitivity to EHEC.” Ingber is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School (HMS) and the Vascular Biology Program at Boston Children’s Hospital, as well as Professor of Bioengineering at Harvard’s John A. Paulson School of Engineering and Applied Sciences.

Because EHEC primarily infects the human colon, the team first assembled a Colon Chip using its microfluidic culture technology and leveraging their recent advances in using intestinal tissue fragments known as organoids as intermediates toward the generation of a highly functional intestinal epithelium that spontaneously forms finger-like projections called intestinal villi in the device. In the Colon Chip, the colon epithelium lines one of two parallel channels (the “intestinal luminal channel”) that are separated by a porous membrane coated with an extracellular matrix (ECM) to which cells preferentially adhere. The opposite channel (the “vascular channel”) is lined by human intestinal endothelial cells that mimic a blood vessel supporting and communicating with the colon epithelium.

The team tested whether the full complexity of soluble molecules produced by complex mouse and human microbiotal communities cultured in bioreactors that mimicked the large intestinal milieu differently affected EHEC infectivity in the human Colon Chips. “It was striking – after addition of human microbiome-specific metabolites the human colon epithelium was badly injured with large lesions appearing where cells died and detached from the tissue, while the same human epithelium exposed to mouse microbiome-specific metabolites were much less effected,” said first-author Alessio Tovaglieri, who performed his graduate work on Ingber’s team as a student at ETH Zurich in Switzerland. “Interestingly, the pathogenic EHEC bacteria did not injure the colon tissue in the absence of microbiome metabolites, and the complex metabolite mixtures themselves had no effect in the absence of EHEC.”

The team was able to demonstrate that the differences in injuries triggered by human and mouse microbiome metabolites were not due to changes in inflammatory cytokines, differences in Shiga toxin production, or alterations in the ability of EHEC to colonize the colon epithelium. To get closer to the actual root causes, they performed transcriptomics analysis, analyzing changes in gene expression in the EHEC bacteria upon exposure to the human and mouse microbiome metabolites and metabolomics analysis to identify differences in the chemical composition of the two metabolite mixtures.

“Genes encoding proteins that act in EHEC chemotaxis and flagellar motility scored highest among all the genes specifically upregulated by the human microbiome’s metabolites that appeared to enhance pathogenicity, and, interestingly, we found that EHEC bacteria exposed to the human microbiome’s metabolites were much more motile,” said Tovaglieri. Flagellae are the complex slender appendages that many bacteria use like motors to move themselves towards food sources (chemotaxis).

Out of 426 metabolites that were present at different levels in the two metabolite mixtures, a combination of four human microbiome metabolites, which all were elevated compared to their levels in the mouse microbiome, was sufficient to increase EHEC motility in a dish. Importantly, they also were sufficient to convert the normally innocuous mouse microbiome’s metabolite mixture into one that facilitates damage to colon tissue in the human Colon Chip device, making it as effective as the human microbiome’s metabolites. Some of these same metabolites are found at much higher levels in children who are also known to be more sensitive to EHEC infection.

“This work has uncovered potential molecular targets that could help alleviate suffering in patients with EHEC if we could develop ways to suppress their production or enhance their removal in humans. The same human Organ Chip approach combined with metabolomics could help to identify other metabolites that mediate protective effects and increase tolerance to other infections in the future. It also may help us to gain further insight into why certain individuals are sensitive to infections while others are tolerant,” said Ingber.


Tagged with:

About author

Related Articles